FDA Watch
Avsnitt

FDA's Regulatory Revisions: Business & Legal Impact on Industry, Part 4 – Consumer Products

Dela

In the final part of our series in collaboration with SkaddenWayne chats with Rachel Turow, Head of Skadden's Regulatory Practice; Amy Van Gelder, Head of Skadden's Chicago Litigation Practice; Brett Fleisher, M&A Partner at Skadden; and Katherine Armstrong, Deputy Director for the National Advertising Division of BBB National Programs. Together, they discuss how the regulatory approach to consumer products is evolving; how companies should respond to a broader and increasingly varied policy environment with multiple regulators; what's happening at FDA with MoCRA implementation; litigation trends across the consumer products sector; how consumer products companies are navigating a more active plaintiffs' bar; issues that are becoming more important in deal-making diligence and transaction structuring; significant risk or opportunity areas over the next year or soand much more.

This episode and the rest of our series do not include the usual Headlines and Resources Links segments.

To subscribe or find out more information about our podcast, visit FDAWatch.net.

Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us ainfo@fdawatch.net.

Music by Dvir Silver from Pixabay. 

Podden och tillhörande omslagsbild på den här sidan tillhör FDA Watch. Innehållet i podden är skapat av FDA Watch och inte av, eller tillsammans med, Poddtoppen.